JPMorgan Reinstates Insmed (INSM) at Overweight
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $123.74 -2.05%
Rating Summary:
32 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
32 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
JPMorgan analyst Jessica Fye reinstates coverage on Insmed (NASDAQ: INSM) with a Overweight rating and a price target of $36.00.
For an analyst ratings summary and ratings history on Insmed click here. For more ratings news on Insmed click here.
Shares of Insmed closed at $24.82 yesterday.
You May Also Be Interested In
- Insmed (INSM) PT Lowered to $175 at JPMorgan
- Oppenheimer Starts Carriage Services (CSV) at Outperform
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
